Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

A medication already prescribed to relieve menopausal symptoms could also help prevent invasive breast cancer. That's the ...

A vegan diet rich in soy reduced severe hot flashes by 92% in postmenopausal women, according to a new study published in ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

A mom was diagnosed with a cancerous brain tumor and given a year to live after suffering from "strange" symptoms - including ...

This latest entry, Everybody's Golf Hot Shots, looks to mark as much by combining the two names into one unified, new entry. There's an interesting twist in the details, though. Digimon Survive ...

In light of former President Biden's prostate cancer diagnosis, retired North Carolina journalist Jim Ware details his own ...

Cardiac effects due to hot flashes are not new. However, the link to Alzheimer’s disease is. “This is another piece of evidence telling us that hot flashes and night sweats may not be as benign as we ...